LivaNova Other Non-Current Liabilities 2010-2025 | LIVN
LivaNova other non-current liabilities from 2010 to 2025. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
| LivaNova Annual Other Non-Current Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $181 |
| 2023 | $174 |
| 2022 | $217 |
| 2021 | $137 |
| 2020 | $269 |
| 2019 | $154 |
| 2018 | $316 |
| 2017 | $69 |
| 2016 | $35 |
| 2015 | $30 |
| 2015 | $7 |
| 2014 | $0 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $7 |
| 2010 | $6 |
| 2009 | $0 |
| LivaNova Quarterly Other Non-Current Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $170 |
| 2024-12-31 | $181 |
| 2024-09-30 | $212 |
| 2024-06-30 | $231 |
| 2024-03-31 | $234 |
| 2023-12-31 | $174 |
| 2023-09-30 | $189 |
| 2023-06-30 | $192 |
| 2023-03-31 | $178 |
| 2022-12-31 | $217 |
| 2022-09-30 | $207 |
| 2022-06-30 | $273 |
| 2022-03-31 | $304 |
| 2021-12-31 | $137 |
| 2021-09-30 | $156 |
| 2021-06-30 | $151 |
| 2021-03-31 | $292 |
| 2020-12-31 | $269 |
| 2020-09-30 | $157 |
| 2020-06-30 | $167 |
| 2020-03-31 | $126 |
| 2019-12-31 | $154 |
| 2019-09-30 | $186 |
| 2019-06-30 | $185 |
| 2019-03-31 | $206 |
| 2018-12-31 | $316 |
| 2018-09-30 | $190 |
| 2018-06-30 | $212 |
| 2018-03-31 | $184 |
| 2017-12-31 | $69 |
| 2017-09-30 | $74 |
| 2017-06-30 | $76 |
| 2017-03-31 | $38 |
| 2016-12-31 | $35 |
| 2016-09-30 | $27 |
| 2016-06-30 | $30 |
| 2016-03-31 | $32 |
| 2015-12-31 | $30 |
| 2015-10-31 | |
| 2015-09-30 | |
| 2015-07-31 | |
| 2015-06-30 | |
| 2015-04-30 | |
| 2015-03-31 | |
| 2015-01-31 | $4 |
| 2014-10-31 | |
| 2014-07-31 | |
| 2014-04-30 | $5 |
| 2014-01-31 | |
| 2013-10-31 | $5 |
| 2013-07-31 | |
| 2013-04-30 | |
| 2013-01-31 | |
| 2012-10-31 | $5 |
| 2012-07-31 | $5 |
| 2012-04-30 | |
| 2012-01-31 | |
| 2011-10-31 | |
| 2011-07-31 | |
| 2011-04-30 | |
| 2011-01-31 | $7 |
| 2010-10-31 | |
| 2010-07-31 | |
| 2010-04-30 | $6 |
| 2010-01-31 | |
| 2009-10-31 | |
| 2009-07-31 | |
| 2009-04-30 | |
| 2009-01-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.398B | $1.253B |
| LivaNova PLC is a medical technology company which focuses on providing treatment for cardiovascular diseases and neuromodulation. The Company's operating units consists of Cardiac Rhythm Management, Cardiac Surgery and Neuromodulation. LivaNova PLC, formerly known as Cyberonics, Inc., is based in London, United Kingdom. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $185.102B | 81.07 |
| Thermo Fisher Scientific (TMO) | United States | $160.563B | 19.42 |
| Edwards Lifesciences (EW) | United States | $45.919B | 30.11 |
| Alcon (ALC) | Switzerland | $43.070B | 29.11 |
| IDEXX Laboratories (IDXX) | United States | $42.738B | 49.12 |
| DexCom (DXCM) | United States | $33.459B | 51.72 |
| IQVIA Holdings (IQV) | United States | $27.702B | 15.52 |
| Mettler-Toledo (MTD) | United States | $24.812B | 29.51 |
| STERIS (STE) | Ireland | $22.211B | 24.46 |
| Waters (WAT) | United States | $18.101B | 25.54 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.184B | 0.00 |
| Hologic (HOLX) | United States | $14.400B | 15.65 |
| Sysmex ADR (SSMXY) | Japan | $10.569B | 29.98 |
| Penumbra (PEN) | United States | $9.268B | 72.74 |
| Masimo (MASI) | United States | $8.767B | 32.34 |
| Globus Medical (GMED) | United States | $7.767B | 18.51 |
| Glaukos (GKOS) | United States | $5.953B | 0.00 |
| Teleflex (TFX) | United States | $5.115B | 8.44 |
| Integer Holdings (ITGR) | United States | $4.169B | 21.84 |
| TransMedics (TMDX) | United States | $3.953B | 85.94 |
| PROCEPT BioRobotics (PRCT) | United States | $3.218B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.099B | 24.07 |
| Veracyte (VCYT) | United States | $2.087B | 29.29 |
| Elekta AB (EKTAY) | Sweden | $1.903B | 17.10 |
| Alphatec Holdings (ATEC) | United States | $1.595B | 0.00 |
| Artivion (AORT) | United States | $1.353B | 126.72 |
| Pulse Biosciences (PLSE) | United States | $1.081B | 0.00 |
| OPKO Health (OPK) | United States | $1.063B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.049B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.949B | 5.05 |
| IRadimed (IRMD) | United States | $0.738B | 37.47 |
| SiBone (SIBN) | United States | $0.738B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.619B | 13.42 |
| Beta Bionics (BBNX) | United States | $0.556B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.548B | 8.53 |
| AxoGen (AXGN) | United States | $0.547B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.538B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.456B | 10.60 |
| Pacific Biosciences Of California (PACB) | United States | $0.438B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.430B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.413B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.391B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.377B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.332B | 0.00 |
| RxSight (RXST) | United States | $0.315B | 0.00 |
| NeuroPace (NPCE) | United States | $0.313B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.274B | 0.00 |
| Neuronetics (STIM) | United States | $0.255B | 0.00 |
| 908 Devices (MASS) | United States | $0.241B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.233B | 14.14 |
| Monogram Orthopaedics (MGRM) | United States | $0.209B | 0.00 |
| CVRx (CVRX) | United States | $0.192B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.191B | 0.00 |
| Inogen (INGN) | United States | $0.180B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.179B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.149B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.140B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.121B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.111B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.092B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.075B | 0.00 |
| InspireMD (NSPR) | United States | $0.072B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 43.20 |
| Spectral AI (MDAI) | United States | $0.068B | 0.00 |
| Hyperfine (HYPR) | United States | $0.062B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.056B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 22.22 |
| Vicarious Surgical (RBOT) | United States | $0.054B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.023B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.022B | 0.00 | |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.51 |